Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease

American Journal of Nephrology - Switzerland
doi 10.1159/000456087
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

S. Karger AG

Related search

TRPP2 and Autosomal Dominant Polycystic Kidney Disease

Biochimica et Biophysica Acta - Molecular Basis of Disease
Molecular MedicineMolecular Biology
2007English

Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease

New England Journal of Medicine
Medicine
2010English

Kidney Volume and Function in Autosomal Dominant Polycystic Kidney Disease

Clinical and Experimental Nephrology
PhysiologyNephrology
2013English

Interstitial Disease of Autosomal Dominant Polycystic Kidney Disease

Journal of Physiology Studies
2014English

Diagnosis and Screening of Autosomal Dominant Polycystic Kidney Disease

Advances in Chronic Kidney Disease
Nephrology
2010English

Ectopic (Pelvic) Autosomal Dominant Polycystic Kidney Disease

Internal Medicine
Internal MedicineMedicine
2010English

Recent Advances in Autosomal-Dominant Polycystic Kidney Disease

Internal Medicine Journal
Internal Medicine
2016English

Seminal Vesicles in Autosomal Dominant Polycystic Kidney Disease

2015English

Intracranial Cysts in Autosomal Dominant Polycystic Kidney Disease

Journal of Neurosurgery
SurgeryNeurology
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy